Science Advisor William Happer to Leave National Security Council
Catherine Offord | Sep 13, 2019
An outspoken critic of the scientific consensus on anthropogenic climate change, Happer is returning to academia after a year in his White House role.
Science Under Maximum Pressure in Iran
David Adam | Sep 13, 2019
From travel restrictions and publishing bans to currency collapse, the restoration of US sanctions has left researchers in Iran reeling.
Cancer Drugs in Development May Be Targeting Wrong Proteins
Shawna Williams | Sep 12, 2019
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Bone Hormone Sparks Fight-or-Flight Response in Mice
Ruth Williams | Sep 12, 2019
A brain-activated, bone-derived hormone called osteocalcin regulates the acute stress response in rodents and possibly humans.
EPA Aims to Drastically Reduce Animal Testing
Emily Makowski | Sep 11, 2019
The agency plans to stop funding virtually all toxicology studies in mammals by 2035.
Stuart Levy, Antibiotic Resistance Researcher, Dies
Emily Makowski | Sep 11, 2019
The Tufts University biologist and physician sounded the alarm on the effects of antibiotic use in animals.
CAR T Immunotherapy May Find New Use in Treating Cardiac Fibrosis
Emma Yasinski | Sep 11, 2019
Scientists show the approach can kill cells that cause hardening of heart tissue in mice.
Newly Described Electric Eel Has Strongest Voltage Yet Measured
Kerry Grens | Sep 10, 2019
The same study also finds there are three species of Electrophorus, rather than one.
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Jef Akst | Sep 10, 2019
The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.
Johns Hopkins Launches Research Center on Psychedelics
Emily Makowski | Sep 9, 2019
The facility, focused on finding treatments for mental health disorders, will be the first of its kind in the US.